Akil C, Xu J, Shen J, Zhang P
bioRxiv. 2025; .
PMID: 40060467
PMC: 11888396.
DOI: 10.1101/2025.02.25.640151.
Swart I, Debski-Antoniak O, Zegar A, de Bouter T, Chatziandreou M, van den Berg M
J Nanobiotechnology. 2025; 23(1):196.
PMID: 40059135
PMC: 11892322.
DOI: 10.1186/s12951-025-03243-y.
Hills F, Jorge F, Burga L, Bostina M
Curr Protoc. 2025; 5(3):e70115.
PMID: 40056094
PMC: 11890022.
DOI: 10.1002/cpz1.70115.
Singh S, Liu Y, Burke M, Rayaprolu V, Stein S, Hasan S
J Struct Biol X. 2025; 11:100123.
PMID: 40046771
PMC: 11880631.
DOI: 10.1016/j.yjsbx.2025.100123.
Xiao W, Jiang W, Chen Z, Huang Y, Mao J, Zheng W
Signal Transduct Target Ther. 2025; 10(1):74.
PMID: 40038239
PMC: 11880366.
DOI: 10.1038/s41392-024-02107-5.
Quality by design for transient RBD-Fc fusion protein production in Chinese hamster ovary cells.
Jivapetthai A, Arunmanee W, Pornputtapong N
Biotechnol Rep (Amst). 2025; 45:e00882.
PMID: 40034964
PMC: 11872631.
DOI: 10.1016/j.btre.2025.e00882.
Intradermal delivery of SARS-CoV-2 RBD3-Fc mRNA vaccines via a needle-free injection system induces robust immune responses in rats.
Wang C, Tang X, Jiang C, Zhang Y, Han B, Sun Y
Front Immunol. 2025; 16:1530736.
PMID: 40034698
PMC: 11872709.
DOI: 10.3389/fimmu.2025.1530736.
production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infection.
Suzuki Y, Miyazaki T, Ida Y, Suzuki T, Itoh Y, Nakao S
Mol Ther Nucleic Acids. 2025; 36(1):102467.
PMID: 40027884
PMC: 11869860.
DOI: 10.1016/j.omtn.2025.102467.
Exploring the effects of N234 and N343 linked glycans to SARS CoV 2 spike protein pocket accessibility using Gaussian accelerated molecular dynamics simulations.
Cheng R, Lim J, Fortuna M, Reyes Jr D, Hans E, Nellas R
Sci Rep. 2025; 15(1):7052.
PMID: 40016249
PMC: 11868416.
DOI: 10.1038/s41598-025-85153-5.
Molecular basis of host recognition of human coronavirus 229E.
Tsai Y, Chien Y, Hsu M, Khoo K, Hsu S
Nat Commun. 2025; 16(1):2045.
PMID: 40016196
PMC: 11868633.
DOI: 10.1038/s41467-025-57359-8.
The effect of cysteine oxidation on conformational changes of SARS-CoV-2 spike protein using atomistic simulations.
Ghasemitarei M, Taeb H, Ghorbi T, Yusupov M, Ala-Nissila T, Bogaerts A
Sci Rep. 2025; 15(1):6890.
PMID: 40011543
PMC: 11865280.
DOI: 10.1038/s41598-025-90918-z.
Simulations of pH and thermal effects on SARS-CoV-2 spike glycoprotein.
Niu Z, Kementzidis G, Rafailovich M, Simon M, Papadopoulos E, Aktas B
Front Mol Biosci. 2025; 12:1545041.
PMID: 40007557
PMC: 11850259.
DOI: 10.3389/fmolb.2025.1545041.
Novel sACE2-Anti-CD16VHH Fusion Protein Surreptitiously Inhibits SARS-CoV-2 Variant Spike Proteins and Macrophage Cytokines, and Activates Natural Killer Cell Cytotoxicity.
Sheikhi A, Baghaie L, Rahbarizadeh F, Safarzadeh Kozani P, Moradian C, Davidi M
Vaccines (Basel). 2025; 13(2).
PMID: 40006745
PMC: 11860277.
DOI: 10.3390/vaccines13020199.
Exploring Asthma as a Protective Factor in COVID-19 Outcomes.
Quinn A, Zhao L, Bell S, Huq M, Fang Y
Int J Mol Sci. 2025; 26(4).
PMID: 40004141
PMC: 11855143.
DOI: 10.3390/ijms26041678.
Selective Control by L. and Its Carotenoid Zeaxanthin on SARS-CoV-2 Virus.
Pennisi R, Gentile D, Trischitta P, Barreca D, Rescifina A, Mandalari G
Int J Mol Sci. 2025; 26(4).
PMID: 40004129
PMC: 11855127.
DOI: 10.3390/ijms26041667.
Mutational Scanning and Binding Free Energy Computations of the SARS-CoV-2 Spike Complexes with Distinct Groups of Neutralizing Antibodies: Energetic Drivers of Convergent Evolution of Binding Affinity and Immune Escape Hotspots.
Alshahrani M, Parikh V, Foley B, Raisinghani N, Verkhivker G
Int J Mol Sci. 2025; 26(4).
PMID: 40003970
PMC: 11855367.
DOI: 10.3390/ijms26041507.
Sequences in the Cytoplasmic Tail Contribute to the Intracellular Trafficking and the Cell Surface Localization of SARS-CoV-2 Spike Protein.
Burkova E, Bakhno I
Biomolecules. 2025; 15(2).
PMID: 40001583
PMC: 11853650.
DOI: 10.3390/biom15020280.
Quantitative Characterization and Prediction of the Binding Determinants and Immune Escape Hotspots for Groups of Broadly Neutralizing Antibodies Against Omicron Variants: Atomistic Modeling of the SARS-CoV-2 Spike Complexes with Antibodies.
Alshahrani M, Parikh V, Foley B, Raisinghani N, Verkhivker G
Biomolecules. 2025; 15(2).
PMID: 40001552
PMC: 11853647.
DOI: 10.3390/biom15020249.
Antibody-dependent enhancement of coronaviruses.
Tao T, Tian L, Ke J, Zhang C, Li M, Xu X
Int J Biol Sci. 2025; 21(4):1686-1704.
PMID: 39990674
PMC: 11844293.
DOI: 10.7150/ijbs.96112.
Transmembrane protease serine 2 (TMPRSS2) inhibitors screened from an Fv-antibody library for preventing SARS-CoV-2 infection.
Jung J, Sung J, Kwon S, Bae H, Kang M, Jose J
RSC Med Chem. 2025; .
PMID: 39990164
PMC: 11843257.
DOI: 10.1039/d4md00992d.